Insider transactions

EDGAR

Vera Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
1 transactions, 5,882 shares
Sum of shares × price per share: 249,985
Open-market sales (code S)
32 transactions, 293,805 shares
Sum of shares × price per share: 11,887,958.8128

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 81

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-15 Filed 2026-09-17Fordyce Marshall Director · Officer: PRESIDENT AND CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)18,5002.8968
53,590.8

Derived: shares × price per share. Exact value 53590.8000.

253,744Direct (D) Yes— Open filing 0001859453-26-000015 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)18,50037
684,500

Derived: shares × price per share. Exact value 684500.

235,244Direct (D) Yes
F1
  • F1 The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
Open filing 0001859453-26-000015 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Fordyce Marshall Director · Officer: PRESIDENT AND CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (18,500) — exercise price 2.8968
Disposed (D)18,5000—488,801Direct (D) Yes
F2
  • F2 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vested monthly thereafter.
Open filing 0001859453-26-000015 Read from the filing’s XML Dispute this row
2026-09-11 Filed 2026-09-14Young Joseph R Officer: SVP, FINANCE, CHIEF ACCT OFFCR
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)5,0003.9396
19,698

Derived: shares × price per share. Exact value 19698.0000.

80,754Direct (D) No— Open filing 0001861684-26-000006 Read from the filing’s XML Dispute this row
2026-09-11 Filed 2026-09-14Young Joseph R Officer: SVP, FINANCE, CHIEF ACCT OFFCR
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (5,000) — exercise price 3.9396
Disposed (D)5,0000—33,589Direct (D) No
F1
  • F1 1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.
Open filing 0001861684-26-000006 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Fordyce Marshall Director · Officer: PRESIDENT AND CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)18,5002.8968
53,590.8

Derived: shares × price per share. Exact value 53590.8000.

253,744Direct (D) Yes— Open filing 0001859453-26-000014 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)18,50035.1158
649,642.3

Derived: shares × price per share. Exact value 649642.3000.

235,244Direct (D) Yes
F1, F2
  • F1 The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.34, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001859453-26-000014 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Fordyce Marshall Director · Officer: PRESIDENT AND CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (18,500) — exercise price 2.8968
Disposed (D)18,5000—507,301Direct (D) Yes
F3
  • F3 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vested monthly thereafter.
Open filing 0001859453-26-000014 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-05Boman Nancy Lee Officer: Chief Regulatory Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
Acquired (A)44,9870—44,987Direct (D) No
F1
  • F1 Represents the number of shares of Class A Common Stock underlying the restricted stock units (RSUs) granted under the Issuer's 2024 Inducement Plan. 1/4th of the RSUs, rounded to the nearest whole share, vest on each of August 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date.
Open filing 0002145711-26-000002 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-05Boman Nancy Lee Officer: Chief Regulatory Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (63,011) — exercise price 32.23
Acquired (A)63,0110—63,011Direct (D) No
F2
  • F2 12/48ths of the shares subject to the stock option will vest and become exercisable on August 3, 2027, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date.
Open filing 0002145711-26-000002 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)46,2502.8968
133,977

Derived: shares × price per share. Exact value 133977.0000.

281,494Direct (D) Yes
F1
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000013 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)1,00040.7762
40,776.2

Derived: shares × price per share. Exact value 40776.2000.

280,494Direct (D) Yes
F2, F3, F1
  • F2 The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F3 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.39 to $41.31, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000013 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)32,55042.0736
1,369,495.68

Derived: shares × price per share. Exact value 1369495.6800.

247,944Direct (D) Yes
F2, F4, F1
  • F2 The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F4 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.40 to $42.39, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000013 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)10,50042.8578
450,006.9

Derived: shares × price per share. Exact value 450006.9000.

237,444Direct (D) Yes
F2, F5, F1
  • F2 The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F5 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.40 to $43.38, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000013 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)2,20043.5947
95,908.34

Derived: shares × price per share. Exact value 95908.3400.

235,244Direct (D) Yes
F2, F6, F1
  • F2 The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F6 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.42 to $43.97, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000013 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (46,250) — exercise price 2.8968
Disposed (D)46,2500—525,801Direct (D) Yes
F1, F7
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
  • F7 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vested monthly thereafter.
Open filing 0001859453-26-000013 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-09Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)1,00040.7762
40,776.2

Derived: shares × price per share. Exact value 40776.2000.

197,244Direct (D) Yes
F1, F2
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.39 to $41.31, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001859453-26-000010 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-09Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)32,55042.0736
1,369,495.68

Derived: shares × price per share. Exact value 1369495.6800.

164,694Direct (D) Yes
F1, F3
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F3 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.40 to $42.39, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001859453-26-000010 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-09Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)10,50042.8578
450,006.9

Derived: shares × price per share. Exact value 450006.9000.

154,194Direct (D) Yes
F1, F4
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F4 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.40 to $43.38, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001859453-26-000010 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-09Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)2,20043.5947
95,908.34

Derived: shares × price per share. Exact value 95908.3400.

151,994Direct (D) Yes
F1, F5
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F5 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.42 to $43.97, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001859453-26-000010 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)18,5002.8968
53,590.8

Derived: shares × price per share. Exact value 53590.8000.

253,744Direct (D) Yes
F1
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on June 23, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000012 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)18,41237.9311
698,387.4132

Derived: shares × price per share. Exact value 698387.4132.

235,332Direct (D) Yes
F2, F3, F1
  • F2 The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F3 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.43 to $38.315, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on June 23, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000012 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)8838.43
3,381.84

Derived: shares × price per share. Exact value 3381.84.

235,244Direct (D) Yes
F2, F1
  • F2 The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on June 23, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000012 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (18,500) — exercise price 2.8968
Disposed (D)18,5000—572,051Direct (D) Yes
F1, F4
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on June 23, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
  • F4 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vested monthly thereafter.
Open filing 0001859453-26-000012 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)18,41237.9311
698,387.4132

Derived: shares × price per share. Exact value 698387.4132.

198,332Direct (D) Yes
F1, F2
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.43 to $38.315, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001859453-26-000008 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)8838.43
3,381.84

Derived: shares × price per share. Exact value 3381.84.

198,244Direct (D) Yes
F1
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
Open filing 0001859453-26-000008 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Meyers James R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (17,084) — exercise price 34.35
Acquired (A)17,0840—17,084Direct (D) No
F1
  • F1 The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Open filing 0001387521-26-000002 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Cheng Andrew Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (17,084) — exercise price 34.35
Acquired (A)17,0840—17,084Direct (D) No
F1
  • F1 The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Open filing 0001778307-26-000002 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26MORRISSEY MICHAEL Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (17,084) — exercise price 34.35
Acquired (A)17,0840—17,084Direct (D) No
F1
  • F1 The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Open filing 0001202096-26-000002 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Oliger Christy J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (17,084) — exercise price 34.35
Acquired (A)17,0840—17,084Direct (D) No
F1
  • F1 The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Open filing 0001822092-26-000005 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26SEIDENBERG BETH C Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (17,084) — exercise price 34.35
Acquired (A)17,0840—17,084Direct (D) No
F1
  • F1 The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Open filing 0001184592-26-000002 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26ENRIGHT PATRICK G Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (17,084) — exercise price 34.35
Acquired (A)17,0840—17,084Direct (D) No
F1
  • F1 The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Open filing 0001253886-26-000004 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Morrison Scott W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (17,084) — exercise price 34.35
Acquired (A)17,0840—17,084Direct (D) No
F1
  • F1 The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Open filing 0001662426-26-000002 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Hall Kimball Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (17,084) — exercise price 34.35
Acquired (A)17,0840—17,084Direct (D) No
F1
  • F1 The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Open filing 0001897965-26-000002 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)18,5002.8968
53,590.8

Derived: shares × price per share. Exact value 53590.8000.

253,744Direct (D) Yes
F1
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on May 12, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000011 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)14,21936.6396
520,978.4724

Derived: shares × price per share. Exact value 520978.4724.

239,525Direct (D) Yes
F2, F3, F1
  • F2 The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F3 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.96 to $36.94, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on May 12, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000011 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)4,28137.0868
158,768.5908

Derived: shares × price per share. Exact value 158768.5908.

235,244Direct (D) Yes
F2, F4, F1
  • F2 The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F4 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.97 to $37.15, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on May 12, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
Open filing 0001859453-26-000011 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-08-12Fordyce Marshall Director · Officer: PRESIDENT AND CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (18,500) — exercise price 2.8968
Disposed (D)18,5000—590,551Direct (D) Yes
F1, F5
  • F1 This amended Form 4 is filed to reflect the option exercise that occurred on May 12, 2026 and correct the amounts reported in Column 5 Amount of Securities Beneficially Owned Following Reported Transaction(s).
  • F5 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vested monthly thereafter.
Open filing 0001859453-26-000011 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-13Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)14,21936.6396
520,978.4724

Derived: shares × price per share. Exact value 520978.4724.

221,025Direct (D) Yes
F1, F2
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.96 to $36.94, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001859453-26-000007 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-13Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)4,28137.0868
158,768.5908

Derived: shares × price per share. Exact value 158768.5908.

216,744Direct (D) Yes
F1, F3
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F3 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.97 to $37.15, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001859453-26-000007 Read from the filing’s XML Dispute this row
2026-04-14 Filed 2026-04-15Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)14,13043.6649
616,985.037

Derived: shares × price per share. Exact value 616985.0370.

244,065Direct (D) Yes
F1, F2, F3
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended,
  • F2 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.25 to $44.24, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • F3 Includes 1,032 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2026.
Open filing 0001859453-26-000006 Read from the filing’s XML Dispute this row
2026-04-14 Filed 2026-04-15Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)7,92144.5784
353,105.5064

Derived: shares × price per share. Exact value 353105.5064.

236,144Direct (D) Yes
F1, F4
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended,
  • F4 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.25 to $45.20, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001859453-26-000006 Read from the filing’s XML Dispute this row
2026-04-14 Filed 2026-04-15Fordyce Marshall Director · Officer: PRESIDENT AND CEO
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)90045.5114
40,960.26

Derived: shares × price per share. Exact value 40960.2600.

235,244Direct (D) Yes
F1, F5
  • F1 This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended,
  • F5 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.25 to $45.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001859453-26-000006 Read from the filing’s XML Dispute this row
2026-03-23 Filed 2026-03-25Wright-Mitchell Jane Officer: Chief Legal Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
Acquired (A)42,4030—42,403Direct (D) No
F1
  • F1 Represents the number of shares of Class A Common Stock underlying the restricted stock units (RSUs) granted under the Issuer's 2024 Inducement Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of May 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date.
Open filing 0001614568-26-000008 Read from the filing’s XML Dispute this row
2026-03-23 Filed 2026-03-25Wright-Mitchell Jane Officer: Chief Legal Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (56,850) — exercise price 40.73
Acquired (A)56,8500—56,850Direct (D) No
F2
  • F2 12/48ths of the shares subject to the stock option will vest and become exercisable on March 23, 2027, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date.
Open filing 0001614568-26-000008 Read from the filing’s XML Dispute this row
2026-03-13 Filed 2026-03-16Young Joseph R Officer: SVP, FINANCE, CHIEF ACCT OFFCR
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)10,0003.9396
39,396

Derived: shares × price per share. Exact value 39396.0000.

75,754Direct (D) No
F1
  • F1 Includes 1,032 shares acquired pursuant to the Company's 2021 Employee Stock Purchase Plan.
Open filing 0001861684-26-000005 Read from the filing’s XML Dispute this row
2026-03-13 Filed 2026-03-16Young Joseph R Officer: SVP, FINANCE, CHIEF ACCT OFFCR
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (10,000) — exercise price 3.9396
Disposed (D)10,0000—38,589Direct (D) No
F2
  • F2 1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.
Open filing 0001861684-26-000005 Read from the filing’s XML Dispute this row
2026-03-05 Filed 2026-03-09Hite Christopher Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Class A Common Stock (24,937) — exercise price 38.85
Acquired (A)24,9370—24,937Direct (D) No
F1
  • F1 The shares subject to the option will vest monthly over a three-year period, subject to the Reporting Person's continuous service on each vesting date.
Open filing 0001814238-26-000005 Read from the filing’s XML Dispute this row
2026-02-23 Filed 2026-02-25Skelton Laurence Matthew Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)1,58241.9839
66,418.5298

Derived: shares × price per share. Exact value 66418.5298.

64,218Direct (D) No
F1, F2, F3
  • F1 The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026.
  • F2 Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a sell-to-cover transaction and does not represent a discretionary trade by the reporting person.
  • F3 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0002108080-26-000004 Read from the filing’s XML Dispute this row
2026-02-23 Filed 2026-02-25JOHNSON DAVID LEE Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)2,57941.9839
108,276.4781

Derived: shares × price per share. Exact value 108276.4781.

45,727Direct (D) No
F1, F2, F3
  • F1 The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026.
  • F2 Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a sell-to-cover transaction and does not represent a discretionary trade by the reporting person.
  • F3 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001733883-26-000006 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–50 of 241

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Deep Track Capital, LP 7,000,000 SH226,030,000 dollarsHigher by 3,000,000 Prior quarter: 4,000,000Open filing 0001856083-26-000006 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager5,728,892 SH184,985,924 dollarsLower by 18,868 Prior quarter: 5,747,760Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Avoro Capital Advisors LLC 5,635,000 SH181,954,150 dollarsLower by 88,888 Prior quarter: 5,723,888Open filing 0001104659-26-127608 Filed 2026-11-16 Dispute this row
DEERFIELD MANAGEMENT COMPANY, L.P. Partly reported under another manager4,338,778 SH140,099,142 dollarsHigher by 422,378 Prior quarter: 3,916,400Open filing 0001213900-26-120609 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager3,301,893 SH106,618,125 dollarsLower by 846,893 Prior quarter: 4,148,786Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Kynam Capital Management, LP 3,000,000 SH96,870,000 dollarsHigher by 109,941 Prior quarter: 2,890,059Open filing 0001907884-26-000017 Filed 2026-11-16 Dispute this row
Sofinnova Investments, Inc. 2,793,987 SH90,217,840 dollarsUnchanged Prior quarter: 2,793,987Open filing 0001104659-26-128032 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager2,792,142 SH90,158,254 dollarsHigher by 18,072 Prior quarter: 2,774,070Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager2,751,324 SH88,841 dollarsLower by 1,261,612 Prior quarter: 4,012,936Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 2,711,252 SH87,546,327 dollarsLower by 44,161 Prior quarter: 2,755,413Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
Eversept Partners, LP 2,361,996 SH76,268,851 dollarsHigher by 149,226 Prior quarter: 2,212,770Open filing 0001697013-26-000007 Filed 2026-11-16 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager2,131,876 SH68,838,277 dollarsHigher by 1,029,770 Prior quarter: 1,102,106Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
First Light Asset Management, LLC 1,960,386 SH63,300,864 dollarsNot in the prior quarter’s filings read Open filing 0001999371-26-025524 Filed 2026-11-16 Dispute this row
FRONTIER CAPITAL MANAGEMENT CO LLC 1,889,027 SH60,996,682 dollarsHigher by 593,622 Prior quarter: 1,295,405Open filing 0001172661-26-005367 Filed 2026-11-16 Dispute this row
Pictet Asset Management Holding SA 1,839,245 SH59,396,597 dollarsHigher by 589,831 Prior quarter: 1,249,414Open filing 0001993888-26-000007 Filed 2026-11-03 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,741,997 SH56,258,892 dollarsHigher by 49,555 Prior quarter: 1,692,442Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
BRAIDWELL LP 1,726,693 SH55,754,917 dollarsHigher by 1,161,969 Prior quarter: 564,724Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager1,662,695 SH53,688,422 dollarsHigher by 71,652 Prior quarter: 1,591,043Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
Integral Health Asset Management, LLC 1,500,000 SH32,290,000 dollarsLower by 250,000 Prior quarter: 1,750,000Open filing 0001172661-26-005192 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager1,420,415 SH45,865,205 dollarsHigher by 39,580 Prior quarter: 1,380,835Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
Woodline Partners LP 1,001,878 SH32,350,641 dollarsHigher by 841 Prior quarter: 1,001,037Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager952,693 SH30,762,456 dollarsHigher by 362,590 Prior quarter: 590,103Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager952,095 SH30,743,210 dollarsHigher by 85,852 Prior quarter: 866,243Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
SCHRODER INVESTMENT MANAGEMENT GROUP Partly reported under another manager864,269 SH27,980,709 dollarsHigher by 353,482 Prior quarter: 510,787Open filing 0001140361-26-044129 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 838,290 SH27,068,384 dollarsHigher by 559,632 Prior quarter: 278,658Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
GREAT POINT PARTNERS LLC Partly reported under another manager808,717 SH26,113,472 dollarsHigher by 207,881 Prior quarter: 600,836Open filing 0001172661-26-005345 Filed 2026-11-16 Dispute this row
Qube Research Technologies Ltd 792,368 SH25,585,563 dollarsLower by 290,811 Prior quarter: 1,083,179Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager687,353 SH22,194,645 dollarsLower by 2,112,106 Prior quarter: 2,799,459Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Balyasny Asset Management L.P. 657,965 SH21,245,690 dollarsHigher by 283,014 Prior quarter: 374,951Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row
Defilade Capital Management, L.P. 652,377 SH21,065,253 dollarsNot in the prior quarter’s filings read Open filing 0002088557-26-000010 Filed 2026-11-16 Dispute this row
Jones Hill Capital LP 652,218 SH21,060,119 dollarsNot in the prior quarter’s filings read Open filing 0002102314-26-000006 Filed 2026-11-13 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager650,463 SH21,003,856 dollarsHigher by 122,610 Prior quarter: 527,853Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
Davern Capital Partners, LP 628,274 SH20,286,967 dollarsHigher by 129,442 Prior quarter: 498,832Open filing 0000905148-26-004762 Filed 2026-11-12 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 625,650 SH20,202,239 dollarsLower by 17,223 Prior quarter: 642,873Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Logos Global Management LP 600,000 SH19,374,000 dollarsLower by 1,600,000 Prior quarter: 2,200,000Open filing 0001172661-26-005476 Filed 2026-11-19 Dispute this row
Candriam S.C.A. 568,560 SH18,425,879 dollarsHigher by 100,461 Prior quarter: 468,099Open filing 0001537014-26-000009 Filed 2026-11-03 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager566,408 SH18,289,314 dollarsLower by 14,718 Prior quarter: 581,126Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 560,312 SH18,092,474 dollarsHigher by 15,299 Prior quarter: 545,013Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager523,130 SH16,891,867 dollarsHigher by 268,948 Prior quarter: 254,182Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
TANG CAPITAL MANAGEMENT LLC Partly reported under another manager500,000 SH16,145,000 dollarsNot in the prior quarter’s filings read Open filing 0001214659-26-014410 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager494,254 SH15,959,462 dollarsHigher by 333,417 Prior quarter: 160,837Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
READYSTATE ASSET MANAGEMENT LP 492,007 SH15,886,906 dollarsHigher by 196,893 Prior quarter: 295,114Open filing 0001214659-26-014366 Filed 2026-11-16 Dispute this row
ARMISTICE CAPITAL, LLC 460,000 SH14,853,400 dollarsHigher by 160,000 Prior quarter: 300,000Open filing 0001315863-26-000784 Filed 2026-11-16 Dispute this row
Longaeva Partners L.P. Partly reported under another manager453,687 SH14,649,553 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-463222 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 442,935 SH14,302,371 dollarsLower by 22,872 Prior quarter: 465,807Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Elmind Capital, LP 436,518 SH14,095,166 dollarsUnchanged Prior quarter: 436,518Open filing 0001013594-26-001197 Filed 2026-11-16 Dispute this row
VOYA INVESTMENT MANAGEMENT LLC Partly reported under another manager419,805 SH13,555,503 dollarsLower by 222,757 Prior quarter: 642,562Open filing 0001068837-26-000006 Filed 2026-11-10 Dispute this row
Ikarian Capital, LLC 400,000 SH12,916,000 dollarsHigher by 90,000 Prior quarter: 310,000Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Put Partly reported under another manager387,100 SH12,499,459 dollarsHigher by 317,600 Prior quarter: 69,500Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Rock Springs Capital Management LP 356,206 SH11,501,892 dollarsLower by 71,378 Prior quarter: 427,584Open filing 0001172661-26-005279 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Sixth Street Partners Management Company, L.P. 545,013 SH
  • ORBIMED ADVISORS LLC 369,596 SH
  • RENAISSANCE TECHNOLOGIES LLC 279,528 SH
  • TD Asset Management Inc 128,070 SH
  • D. E. Shaw Co., Inc. 74,509 SH
  • Birchview Capital, LP 57,758 SH
  • Trexquant Investment LP 54,608 SH
  • Man Group plc 50,346 SH
  • DIADEMA PARTNERS LP 50,000 SH
  • Swedbank AB 50,000 SH
  • Neo Ivy Capital Management 48,937 SH
  • Point72 Asset Management, L.P. 40,563 SH
  • Knott David M Jr 26,000 SH
  • SG Americas Securities, LLC 25,358 SH
  • Verdad Advisers, LP 23,487 SH
  • NOMURA HOLDINGS INC 20,000 SH
  • Jupiter Topco LLC 17,658 SH
  • Y-Intercept (Hong Kong) Ltd 15,391 SH
  • INTECH INVESTMENT MANAGEMENT LLC 14,829 SH
  • Cinctive Capital Management LP 12,402 SH
  • CANADA PENSION PLAN INVESTMENT BOARD 11,900 SH
  • ExodusPoint Capital Management, LP 11,191 SH
  • Allianz Asset Management GmbH 10,500 SH
  • E Fund Management Co., Ltd. 10,359 SH
  • NINE MASTS CAPITAL Ltd 9,434 SH
  • MML INVESTORS SERVICES, LLC 9,153 SH
  • DRW Securities, LLC 7,274 SH
  • PSP Research LLC 7,000 SH
  • Financiere des Professionnels - Fonds d'investissement inc. 6,949 SH
  • VARCOV Co. 6,616 SH
  • XPONANCE LLC 6,281 SH
  • ALLSTATE CORP 6,263 SH
  • Fiduciary Trust Co 5,259 SH
  • SIMPLEX TRADING, LLC 4,707 SH
  • MERCER GLOBAL ADVISORS INC /ADV 1,815 SH
  • Pacer Advisors, Inc. 1,227 SH
  • ACADIAN ASSET MANAGEMENT LLC 896 SH
  • Graticule Asia Macro Advisors LLC 260 SH
  • SMA Capital LLC 239 SH
  • Persistent Asset Partners Ltd 127 SH
  • Integrated Wealth Concepts LLC 98 SH
  • BERTHEL, FISHER COMPANY FINANCIAL SERVICES, INC. 9 SH
  • Ameritas Advisory Services, LLC 7 SH
  • Hughes Financial Services, LLC 3 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Avoro Capital Advisors LLC Class A Common Stock, $0.001 par value per share7.825,635,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0000902664-26-004552 Dispute this row
Behzad Aghazadeh Class A Common Stock, $0.001 par value per share7.825,635,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0000902664-26-004552 Dispute this row
Deep Track Capital, LP Class A common stock, $0.001 par value per share9.717,000,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-005080 Dispute this row
Deep Track Biotechnology Master Fund, Ltd. Class A common stock, $0.001 par value per share9.717,000,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-005080 Dispute this row
David Kroin Class A common stock, $0.001 par value per share9.717,000,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-005080 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK3.82,753,14809/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0000080255-26-000722 Dispute this row
STATE STREET CORPORATION COMMON STOCK4.63,301,893.0009/30/2026 Filed 2026-11-10SCHEDULE 13GOpen filing 0000093751-26-000740 Dispute this row
Kynam Capital Management, LP Class A common stock, $0.001 par value per share4.01006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001907884-26-000015 Dispute this row
Kynam Capital Management GP, LLC Class A common stock, $0.001 par value per share4.01006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001907884-26-000015 Dispute this row
Yue Tang Class A common stock, $0.001 par value per share4.01006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001907884-26-000015 Dispute this row
STATE STREET CORPORATION COMMON STOCK5.84,148,786.0006/30/2026 Filed 2026-08-07SCHEDULE 13GOpen filing 0000093751-26-000554 Dispute this row
BlackRock, Inc. Class A Stock7.45,340,52206/30/2026 Filed 2026-07-30SCHEDULE 13G/AAmendment 1Open filing 0002012383-26-003123 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK6.44,573,68403/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 3Open filing 0000080255-26-000426 Dispute this row
Point72 Asset Management, L.P. Class A Common Stock, par value $0.001 per share1.71,229,525.0003/25/2026 Filed 2026-04-01SCHEDULE 13GOpen filing 0000902664-26-001831 Dispute this row
Point72 Capital Advisors, Inc. Class A Common Stock, par value $0.001 per share1.71,229,525.0003/25/2026 Filed 2026-04-01SCHEDULE 13GOpen filing 0000902664-26-001831 Dispute this row
Steven A. Cohen Class A Common Stock, par value $0.001 per share1.71,229,525.0003/25/2026 Filed 2026-04-01SCHEDULE 13GOpen filing 0000902664-26-001831 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 1Open filing 0000102909-26-002499 Dispute this row
Deep Track Capital, LP Class A common stock, $0.001 par value per share5.503,921,362.0003/04/2026 Filed 2026-03-11SCHEDULE 13GOpen filing 0001172661-26-001342 Dispute this row
Deep Track Biotechnology Master Fund, Ltd. Class A common stock, $0.001 par value per share5.503,921,362.0003/04/2026 Filed 2026-03-11SCHEDULE 13GOpen filing 0001172661-26-001342 Dispute this row
David Kroin Class A common stock, $0.001 par value per share5.503,921,362.0003/04/2026 Filed 2026-03-11SCHEDULE 13GOpen filing 0001172661-26-001342 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK7.75,461,98812/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0000080255-26-000281 Dispute this row
FMR LLC CLASS A COMMON STOCK4.12,885,853.0012/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 6Open filing 0000315066-26-000540 Dispute this row
Abigail P. Johnson CLASS A COMMON STOCK4.12,885,853.0012/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 6Open filing 0000315066-26-000540 Dispute this row
The Vanguard Group Common Stock5.033,570,40112/31/2025 Filed 2026-01-30SCHEDULE 13GOpen filing 0000102909-26-000262 Dispute this row
Sofinnova Venture Partners X, L.P. ("SVP X") Class A Common Stock, $0.001 par value3.92,793,987.0012/10/2025 Filed 2026-03-05SCHEDULE 13D/AAmendment 5Open filing 0001104659-26-023756 Dispute this row
Sofinnova Management X, L.P. ("SM X LP") Class A Common Stock, $0.001 par value3.92,793,987.0012/10/2025 Filed 2026-03-05SCHEDULE 13D/AAmendment 5Open filing 0001104659-26-023756 Dispute this row
Sofinnova Management X-A, L.L.C. ("SM X LLC") Class A Common Stock, $0.001 par value3.92,793,987.0012/10/2025 Filed 2026-03-05SCHEDULE 13D/AAmendment 5Open filing 0001104659-26-023756 Dispute this row
Dr. James I. Healy ("Healy") Class A Common Stock, $0.001 par value3.92,793,987.0012/10/2025 Filed 2026-03-05SCHEDULE 13D/AAmendment 5Open filing 0001104659-26-023756 Dispute this row
Dr. Maha Katabi ("Katabi") Class A Common Stock, $0.001 par value4.02,847,837.0012/10/2025 Filed 2026-03-05SCHEDULE 13D/AAmendment 5Open filing 0001104659-26-023756 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK5.73,666,59809/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0000080255-25-000840 Dispute this row
Kynam Capital Management, LP Class A common stock, $0.001 par value per share5.373,426,88706/30/2025 Filed 2025-08-14SCHEDULE 13GOpen filing 0001085146-25-005108 Dispute this row
Kynam Capital Management GP, LLC Class A common stock, $0.001 par value per share5.373,426,88706/30/2025 Filed 2025-08-14SCHEDULE 13GOpen filing 0001085146-25-005108 Dispute this row
Yue Tang Class A common stock, $0.001 par value per share5.373,426,88706/30/2025 Filed 2025-08-14SCHEDULE 13GOpen filing 0001085146-25-005108 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,620,749 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201537,836
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

Filings made before the SEC required XML are listed, not extracted.

Back to Vera Therapeutics, Inc.